Enjoy complimentary customisation on priority with our Enterprise License!
The global digital pathology market size is estimated to grow by USD 1.12 billion at a CAGR of 16.98% between 2023 and 2028. The digital pathology market represents a burgeoning segment in the healthcare industry, characterized by the adoption of digital imaging technology for capturing, managing, and analyzing pathology slides and specimens. Fueled by the proliferation of technological innovations in healthcare facilities, this sector experiences continuous growth. Healthcare professionals increasingly demand enhanced efficiency and quicker results, driving market expansion. Furthermore, the integration of digital solutions in educational and training settings significantly contributes to the market's development. Key technological advancements include artificial intelligence, machine learning, and telepathology, which streamline workflows and improve diagnostic accuracy. The digital pathology market's future looks promising, with increasing collaboration between industry players and research institutions to drive innovation and expand its reach.
To learn more about this report, Download Report Sample
The market share growth by the digital slide scanner segment will be significant during the forecast period. The digital slide scanner segment accounted for the maximum share by-product in the global market in 2022. Factors such as increased adoption of research activities in academic institutions and enhanced resolution of the slide images are expected to drive the growth of the digital slide scanner segment during the forecast period.
Get a glance at the market contribution of various segments Download PDF Sample
The digital slide scanner segment was valued at USD 363.40 million in 2018. Growing technological advancement in the magnification and scanning of slides is expected to propel further growth of the segment. Moreover, the rising internet bandwidth connectivity and technological developments by companies in the market are propelling market growth. Such developments are expected to propel the growth of the segment, which, in turn, is expected to propel the growth of the market in focus during the market growth and forecasting period.
For more insights about the market share of various regions Download PDF Sample now!
North America is estimated to contribute 39% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period. North America dominates the global market, with the US leading the market in the region. Growing US FDA approval of whole slide imaging systems used in workflows and increasing adoption of advanced pathology practices drive the growth of the market in North America. In addition, the presence of a large number of key companies in the region that offer products with integrated AI and automation technologies has also helped ease the accessibility to products in the regional market. Furthermore, these market companies are witnessing favorable market conditions due to the increasing approval of systems in the region. Such factors have surged the growth opportunities in the US market and have substantially promoted market companies to develop advanced products. This has promoted the swift growth of the market in the region.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
3DHISTECH Ltd., Apollo Enterprise Imaging Corp., Co Diagnostics Inc., Corista, Danaher Corp., F. Hoffmann La Roche Ltd., General Electric Co., Hamamatsu Photonics KK, Huron Digital Pathology, Indica Labs Inc., Inspirata Inc., Kanteron Systems SLU, Koninklijke Philips N.V., Mikroscan Technologies Inc., Objective Pathology Services, Olympus Corp., Proscia Inc., Sectra AB, Visiopharm AS, and XIFIN Inc.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market is witnessing significant evolution driven by advancements in technology and healthcare innovation. With a focus on diagnosis and imaging solutions, digital pathology software is transforming medical research and laboratory analysis. As demand for cancer diagnostics and disease research increases, the market continues to evolve with digitalization trends and ongoing innovation, shaping the future of healthcare analysis and slide imaging. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic market research and growth analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Increasing demand for high productivity and reduced turnaround time among end-users is a prominent factor driving the healthcare technology market. This digitalization of pathology has improved diagnosis and imaging, reducing errors in interpretations. The key advantage is the high productivity and reduced turnaround time achieved through high-throughput scanning and advanced algorithms. Growing disease prevalence has increased hospitals' and laboratories' workload, fueling demand for timely diagnoses. To meet this demand, automated technologies like these systems are adopted.
Market players continuously enhance their systems with high-speed scanning capabilities, such as F. Hoffmann-La Roche's Ventana DP 200 slide scanner, Danaher's Aperio Digital Pathology Slide Scanners, and Huron Technologies International's TissueScope iQ. Software platforms like Visiopharm AS's Oncotopix and Definiens' Tissue Phenomics further drive the global systems market growth.
Integration of Artificial Intelligence (AI) into these pathology systems is the key trend impacting the global market growth. The advent of IoT in pathology laboratory services as a part of digitalization in healthcare has enabled the use of smarter and interoperable laboratory technologies through connected systems. The data is largely contributing to the development of big healthcare data. For instance, a single laboratory facility using a system generates between 1 and 1.5 PB of data each year.
In addition, the reduced cost of cloud-based storage services has eased concerns regarding the storage of data collected through connected systems. The cost of storing laboratory data is expected to reduce by about 98.98% during 2015-2030. This is expected to reduce the additional cost involved in the storage of such pathology data to some extent, making it more accessible to end-users.
Integration in the existing infrastructure of end-users is a major challenge restraining the growth of market. Market players offering software and services confront significant hurdles in system integration. Their key challenge is to efficiently integrate these systems in a cost-effective manner while complying with DICOM requirements. Developing software that supports large, high-definition pathological image datasets poses complexities, leading to the creation of intricate software platforms. Integrating such complex software with end-user IT infrastructure for real-time data storage and retrieval through connected technologies is a formidable task.
Additionally, designing and installing such systems within existing IT architectures of end-users raises concerns about data sharing between separate applications. Poor scaling and integration may cause system failures during critical periods. Legacy IT infrastructure also challenges seamless digital pathology system performance, requiring market players to adopt scalable architecture. However, this task demands considerable time, resources, and cost, potentially impeding market players' developments.
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Customer Landscape
The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Billion" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
The market is witnessing a transformative shift propelled by technological advances and AI-powered digital imaging innovations. With the rise in new cancer cases and the pressing need to address disparities in healthcare, there's a growing momentum to digitize healthcare procedures. Leading companies like 3DHISTECH, Paige, and Akoya Biosciences are at the forefront, offering cutting-edge digital pathology solutions and AI tools for cancer diagnostics. Collaborations such as Paige's partnership with Ohio State Wexner Medical Center and advancements in AI-based digital pathology underscore the market's dynamic nature. As the industry embraces automation and neural network technologies, the future outlook promises enhanced efficiency in disease diagnosis and patient care, driving revenue generation potential and fostering innovation in the medical science realm.
However, there exists a disparity in access to advanced tools and technologies. The advent of digital slides has revolutionized the field, allowing pathologists to analyze specimens with greater clarity and efficiency using a scanning device connected to a computer screen or mobile device. With advanced pathology techniques and diagnostic services, digital pathology scanners enable pathologists to achieve significant cost savings and attract investments in innovative solutions like 3DHISTECHE and predia. Collaborative efforts, such as the Pathology Innovation Incubator, drive progress in the field, empowering pathologists to deliver superior patient care.
Digital Pathology Market Scope |
|
Report Coverage |
Details |
Page number |
172 |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 16.98% |
Market growth 2024-2028 |
USD 1.12 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
14.12 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 39% |
Key countries |
US, UK, Germany, France, and Canada |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
3DHISTECH Ltd., Apollo Enterprise Imaging Corp., Co Diagnostics Inc., Corista, Danaher Corp., F. Hoffmann La Roche Ltd., General Electric Co., Hamamatsu Photonics KK, Huron Digital Pathology, Indica Labs Inc., Inspirata Inc., Kanteron Systems SLU, Koninklijke Philips N.V., Mikroscan Technologies Inc., Objective Pathology Services, Olympus Corp., Proscia Inc., Sectra AB, Visiopharm AS, and XIFIN Inc. |
Market dynamics |
Parent market analysis, market growth and trends, market forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for market forecast period. |
Customization purview |
If our market analysis and report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.